A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z
NCT02451891
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
38
Enrollment
OTHER
Sponsor class
Stopped
Long term follow up will take place in a new clinical trial.
Conditions
Ebola Virus Disease
Interventions
BIOLOGICAL:
MVA-EBO Z
BIOLOGICAL:
ChAd3-EBO Z
Sponsor
University of Oxford